30 Years of Evidence
Featured Content
Radiosurgery society
Frameless Radiosurgery is a Safe and Effective Treatment for Medically-Refractory Trigeminal Neuralgia in Elderly Patients
Radiosurgery society
Efficacy and Safety of Donut-Shaped Circumferential Spine CyberKnife Stereotactic Body Radiotherapy for Metastatic Spine Disease
Radiosurgery society
Long-Term Outcomes of Vestibular Schwannoma Treated with Stereotactic Radiosurgery: A Retrospective Study from a Single Institution
Evaluation of TomoTherapy dose calculations with intrafractional motion and motion compensation
Chao EH, Lucas D, Schnarr E | Med Phys | 2018
Characterization of imaging performance of a novel helical kVCT for use in image-guided and adaptive radiotherapy – PubMed (nih.gov)
Tegtmeier RC, Ferris WS, Bayouth JE, Miller JR, and Culberson WS | J Appl Clin Med Phys | 2022
Feasibility of image-guided robotic radiotherapy using three fractions for uveal melanoma
Choi SY, Kim MS, Yoo SY, Cho CK, Lhee CH, Lee DH, Kang JK, Shin YJ | Tumori | 2009
Stereotactic Radiosurgery and Fractionated Stereotactic Radiation Therapy for the Treatment of Uveal Melanoma
Yazici G, Kiratli H, Ozyigit G, Sari SY, Cengiz M, Tarlan B, Mocan BO, Zorlu F | Int J Radiat Oncol Biol Phys | 2017
Incidence of secondary glaucoma after treatment of uveal melanoma with robotic radiosurgery versus brachytherapy
Siedlecki J, Reiterer V, Leicht S, Foerster P, Kortüm K, Schaller U, Priglinger S, Fuerweger C, Muacevic A, Eibl-Lindner K | Acta Ophthalmol | 2017
Robotic assisted CyberKnife radiosurgery for the treatment of iris melanoma
Schmelter V, Heidorn S, Muacevic A, Priglinger SG, Foerster P, Liegl R | Melanoma Res | 2021
Robotic CyberKnife radiosurgery for small choroidal melanomas – PubMed (nih.gov)
Valerie Schmelter, Theresa Hofmann, Frederick Schneider, Constance Weber, Christoph Fuerweger, Alexander Muacevic, Siegfried G Priglinger, Paul Foerster, Raffael Liegl | Melanoma Res | 2022
Fiducial-free CyberKnife stereotactic body radiation therapy (SBRT) for single vertebral body metastases: acceptable local control and normal tissue tolerance with 5 fraction approach
Gill B, Oermann E, Ju A, Suy S, Yu X, Rabin J, Kalhorn C, Nair MN, Voyadzis JM, Unger K, Collins SP, Harter KW, Collins BT | Front Oncol | 2012